Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

Kanesa-thasan, N; Smucny, J J; Hoke, C H; Marks, D H; Konishi, E; Kurane, I; Tang, D B; Vaughn, D W; Mason, P W; Shope, R E

Kanesa-thasan, N; Smucny, J J; Hoke, C H; Marks, D H; Konishi, E; Kurane, I; Tang, D B; Vaughn, D W; Mason, P W; Shope, R E.

Affiliation

Kanesa-thasan N; Department of Virus Diseases, DCD&I, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, MD 20910, Silver Spring, USA.

Vaccine ; 19(4-5): 483-91, 2000 Oct 15.

Article in En | MEDLINE | ID: mdl-11027812

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Poxviridae / Vaccinia / Viral Vaccines / Encephalitis Virus, Japanese Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Vaccine Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Países Bajos

Search on Google

Add to My VHL

XML

PubMed Links